What is the P/E ratio of Finekem Laboratories Pvt . (Amalgamated)?

The latest standalone P/E ratio of Finekem Laboratories Pvt . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Finekem Laboratories Pvt . (Amalgamated)?

The latest standalone P/B ratio of Finekem Laboratories Pvt . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Finekem Laboratories Pvt . (Amalgamated)?

The 52-week high of Finekem Laboratories Pvt . (Amalgamated) is Rs. and the 52-week low is Rs. .

Finekem Laboratories Pvt Ltd. (Amalgamated) - Stock Valuation and Financial Performance

Name: Finekem Laboratories Pvt . (Amalgamated)
Brand: Finekem Laboratories Pvt . (Amalgamated)

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Finekem Laborato

Based on:

Data

M-Cap below 100cr DeciZen not available

Finekem Laboratories Pvt Ltd. (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Finekem Laborato:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	TTM
ROCE % ⓘ	-30.8%	-38.9%	-14.2%	-18.5%	8.1%	3.7%	-24.4%	-36.5%	161.6%	33.2%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	1.4	1.4	3.5	7.9	12	11.3	11.6	11.5	10.5	11
Sales YoY Gr.	-	NA	-6.3%	155.6%	129.3%	51.6%	-6%	3%	-1%	-8.4%	-
Adj EPS ⓘ	-24.1	-32.1	-26.1	-54.1	25.9	10.8	-45.7	-57.7	-85.1	-89.5	0
YoY Gr.	-	NA	NA	NA	NA	-58.3%	-522.6%	NA	NA	NA	-
BVPS (₹) ⓘ	-14.3	-44.3	-70.4	-124.4	-98.7	-91.8	-136.8	-225.8	-324.3	-432	0
Adj Net Profit ⓘ	-0.8	-1.1	-0.9	-1.8	0.9	0.4	-1.6	-2	-2.9	-3	0
Cash Flow from Ops. ⓘ	0	0	0	0	-3	4.1	3	-4.6	14.2	-5.6	-
Debt/CF from Ops. ⓘ	0	0	0	0	-4.9	2.8	2.9	-3.1	0.1	-1.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	5.9%	-2.2%	-8.4%
Adj EPS ⓘ	NA	-228.1%	NA	NA
BVPSⓘ	NA	NA	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	TTM
Return on Equity % ⓘ	-12135.2	145.8	45.5	55.5	-23.3	-11.4	40	31.8	30.9	23.7	0
Op. Profit Mgn % ⓘ	0	-94.9	-31.2	-30.5	23.8	12.4	-4.7	-6.8	-10.8	-10.2	NAN
Net Profit Mgn % ⓘ	0	-75.4	-65.4	-53.1	11.1	3.1	-13.7	-16.8	-25	-28.8	0
Debt to Equity ⓘ	-5.5	-3	-5	-3.4	-4.5	-3.7	-1.9	-1.9	-0.1	-0.6	-
Working Cap Days ⓘ	0	296	407	266	215	184	244	249	206	257	0
Cash Conv. Cycle ⓘ	0	824	-165	-479	69	31	92	74	41	49	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Finekem Laboratories Pvt Ltd. (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	10.5	-
BVPS (₹.) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	-15	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	49.1

Management X-Ray of Finekem Laborato:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Finekem Laborato

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Finekem Laborato

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Sales	0	1.44	1.35	3.45	7.91	11.99	11.27	11.61	11.50	10.53
Operating Expenses ⓘ	0.82	2.81	1.77	4.50	6.03	10.69	11.79	13.91	13.40	12.48
Manufacturing Costs	0	0	0	0	1.94	3.21	3.89	4.36	4.55	4.39
Material Costs	0	0	0	0	3.10	5.82	6.46	6.48	6.74	5.34
Employee Cost	0	0	0	0	0.56	0.76	0.71	0.64	0.50	0.43
Other Costs ⓘ	0.82	2.81	1.77	4.50	0.43	0.89	0.73	2.43	1.62	2.32
Operating Profit ⓘ	-0.82	-1.37	-0.42	-1.05	1.88	1.30	-0.53	-2.30	-1.89	-1.95
Operating Profit Margin (%)	-	-94.9%	-31.2%	-30.5%	23.7%	10.8%	-4.7%	-19.8%	-16.5%	-18.5%
Other Income ⓘ	0	0	0	0	0.11	0.11	0.16	0.29	0.26	0.15
Interest ⓘ	0	0	0	0	0	0	0	0	0.20	0.48
Depreciation ⓘ	0	-0.28	0.46	0.67	1.11	1.18	1.16	1	1.51	1.36
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.82	-1.09	-0.88	-1.72	0.87	0.23	-1.53	-3.01	-3.33	-3.65
Tax ⓘ	0	0	0	0.11	0	0	0	0	0	0
Profit After Tax	-0.82	-1.09	-0.88	-1.83	0.87	0.23	-1.53	-3.01	-3.33	-3.65
PAT Margin (%)	-	-75.4%	-65.4%	-53.1%	11.0%	1.9%	-13.5%	-26.0%	-29.0%	-34.6%
Adjusted EPS (₹)	0.0	-32.1	-26.1	-54.1	25.8	6.9	-45.1	-89.0	-98.5	-107.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Equity and Liabilities
Shareholders Fund	-0.48	-1.50	-2.38	-4.21	-3.34	-3.11	-4.63	-7.64	-10.98	-14.62
Share Capital ⓘ	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34
Reserves ⓘ	-0.82	-1.84	-2.72	-4.55	-3.68	-3.44	-4.97	-7.98	-11.32	-14.96
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	2.64	4.45	11.87	14.47	14.86	11.54	8.85	14.13	1.10	8.25
Long Term Debt	2.64	4.45	11.87	14.47	0	0	0	0	0	0
Short Term Debt	0	0	0	0	14.86	11.54	8.85	14.13	1.10	8.25
Trade Payables	0.65	0.26	0.77	1.60	2.73	1.59	1.38	2.78	2.64	3.14
Others Liabilities ⓘ	0.55	0.06	0.12	3.60	0.44	4.02	11.05	4.41	20.25	18.61
Total Liabilities ⓘ	3.37	3.27	10.38	15.46	14.70	14.04	16.65	13.68	13.01	15.38
Fixed Assets
Gross Block	2.53	2.34	2.95	8.09	10.66	10.95	11.95	11.95	13.73	13.82
Accumulated Depreciation	0.31	0.28	0.74	1.41	2.53	3.70	4.86	5.86	7.37	8.73
Net Fixed Assetsⓘ	2.23	2.06	2.21	6.68	8.14	7.24	7.09	6.09	6.37	5.10
CWIP ⓘ	0	0	6.30	2.33	0.01	0.75	0.10	0.65	0.04	1.16
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.66	0.70	0.49	1.94	3.41	2.09	3.85	1.85	2.23	3.56
Trade Receivables	0.19	0.28	0.33	0.35	1.31	0.93	1.34	1.93	1.18	1.57
Cash Equivalents	0	0	0.06	3.22	0.33	0.08	0.01	0.17	0.21	0.38
Others Assetsⓘ	0.28	0.23	0.98	0.93	1.51	2.94	4.25	2.98	2.97	3.62
Total Assets ⓘ	3.37	3.27	10.38	15.46	14.70	14.04	16.65	13.68	13.01	15.38

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Cash Flow From Operating Activity ⓘ	-3.04	4.10	3.03	-4.57	14.20	-5.62
PBT ⓘ	0.87	0.23	-1.53	-3.01	-3.33	-3.65
Adjustment ⓘ	1.14	1.46	1.15	1.18	2.40	2.73
Changes in Working Capital ⓘ	-5.05	2.45	3.4	-2.74	15.14	-4.71
Tax Paid ⓘ	0	-0.04	0	0	0	0
Cash Flow From Investing Activity ⓘ	-0.25	-1.02	-0.40	-0.55	-1.13	-1.41
Capex	-0.25	-1.02	-0.40	-0.55	-1.13	-1.36
Net Investments	0	0	0	0	0	-0.05
Others ⓘ	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0.40	-3.32	-2.69	5.28	-13.03	7.15
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.40	-3.32	-2.69	5.28	-13.03	7.15
Interest Paid ⓘ	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0
Net Cash Flow ⓘ	-2.89	-0.25	-0.07	0.16	0.04	0.12

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Ratios
ROE (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ROCE (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0	0.43	0.2	0.27	0.53	0.84	0.75	0.78	0.87	0.76
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	3.48	-19.87	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	60	83	36	38	34	36	50	49	47
Inventory Days	0	172	161	128	122	83	94	88	64	98
Payable Days	0	0	0	0	255	135	84	117	147	197

Finekem Laboratories Pvt Ltd. (Amalgamated) Stock News

Finekem Laboratories Pvt Ltd. (Amalgamated) FAQs

What is the share price of Finekem Laborato?

Company share prices are keep on changing according to the market conditions. The closing price of Finekem Laborato on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Finekem Laborato?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Finekem Laborato stood at ₹0.00.